Biotechnology
News Category
VERAXA Biotech Receives Regulatory Guidance from German Institute for Lead BiTAC-TCE Program
VERAXA Biotech has received Scientific Advice from Germany's Paul-Ehrlich-Institute supporting its development strategy for the lead BiTAC-TCE candida...
Onco-Innovations Advances Precision Oncology with Biomarker-Driven Cancer Therapy ONC010
Onco-Innovations is developing ONC010, a nanoparticle-encapsulated PNKP inhibitor for biomarker-selected cancers, aligning with the industry shift tow...
Lantern Pharma Receives U.S. Patent Allowance for Biomarker-Based Cancer Treatment Methods
Lantern Pharma announced a U.S. patent allowance for methods using a three-gene biomarker signature to identify patients with ovarian, liver, kidney, ...
VERAXA Biotech Names Christoph Erkel as Chief Scientific Officer to Lead BiTAC Platform Expansion
VERAXA Biotech AG appointed Christoph Erkel as CSO to advance its proprietary BiTAC platform for solid tumor cancer therapies, succeeding Rick Austin.
iOrganBio Adds Harvard Stem Cell Expert Lee L. Rubin to Scientific Advisory Board
iOrganBio appointed Lee L. Rubin, Ph.D., a leading stem cell biologist from Harvard, to its Scientific Advisory Board to advance its AI-powered CellFo...
BioAdaptives Completes Manufacturing Readiness for Wellness Product Launch
BioAdaptives Inc. has completed commercial manufacturing and supply chain setup for its MyndSystem and Xcellara wellness platforms, targeting global c...
Creative Biolabs Expands Microfluidics Portfolio to Accelerate High-Throughput Antibody Discovery
Creative Biolabs has launched an integrated microfluidics platform combining droplet generation systems, customizable chips, and immune checkpoint ser...
Quantum BioPharma Targets Neurological Disorders with Novel Therapies for MS and Alcohol Intoxication
Quantum BioPharma is advancing a two-pronged approach to brain disorders, focusing on multiple sclerosis with its patented Lucid-MS and on alcohol int...
Oncotelic Therapeutics Publishes Preclinical Data Supporting Intravenous Cancer Therapy Sapu003
Oncotelic Therapeutics released peer-reviewed preclinical data for Sapu003, an intravenous everolimus formulation, showing improved pharmacokinetics a...
Kairos Pharma Collaborates with Bayer to Test Combination Therapy for Advanced Prostate Cancer
Kairos Pharma Ltd. has partnered with Bayer to evaluate its antibody ENV-105 in combination with Bayer's XOFIGO for metastatic castration-resistant pr...
VERAXA Biotech Receives Positive Regulatory Feedback from Germany for Its BiTAC-TCE Platform
VERAXA Biotech AG announced it has received Scientific Advice from Germany's Paul-Ehrlich-Institute supporting the development strategy for its lead B...
VivoSim Labs Raises $4 Million in Private Placement with Healthcare Institutional Investor
VivoSim Labs secures $4 million through a private placement to fund working capital and general corporate purposes, while also amending existing warra...
Greenwich LifeSciences Advances Phase 3 Trial for Breast Cancer Immunotherapy GLSI-100
Greenwich LifeSciences reported progress in its Phase 3 FLAMINGO-01 trial for GLSI-100, including DSMB approval to continue, expanded enrollment to 2,...
Quantum BioPharma Targets Two Major Neurological Disorders with Novel Pipeline
Quantum BioPharma is developing Lucid-MS for multiple sclerosis and unbuzzd for alcohol intoxication, addressing significant unmet needs in neurologic...
American Fusion Secures Texas Registration for Texatron Fusion Engine Testing
American Fusion Inc. has received a Texas Certificate of Registration for Industrial Radiation Machines, enabling testing of its Texatron Fusion Engin...
WHO-Commissioned Study Finds No Evidence Mobile Phones Cause Brain Cancer
A comprehensive review commissioned by the World Health Organization found no link between mobile phone use and brain cancer, potentially easing long-...
Quantum BioPharma Reaches Halfway Mark in MS Imaging Study with Promising Early Data
Quantum BioPharma announced its PET imaging study for multiple sclerosis has enrolled half its patients and shown encouraging early signals, potential...
GeoVax's GEO-MVA Platform Aligns with ASPR's Five-Year $66.9 Billion Biodefense Strategy
GeoVax highlights that its GEO-MVA vaccine platform aligns with the U.S. Department of Health and Human Services' five-year, $66.9 billion medical cou...
VERAXA Biotech Receives Regulatory Feedback for BiTAC-TCE Cancer Therapy Platform
VERAXA Biotech announced regulatory feedback from Germany's Paul-Ehrlich-Institute supporting its BiTAC-TCE cancer therapy platform, an early step tow...
VERAXA Biotech Receives Regulatory Feedback for BiTAC-TCE Cancer Therapy Platform, Advancing Toward Clinical Development
VERAXA Biotech announced it received Scientific Advice from Germany's Paul-Ehrlich-Institute for its BiTAC-TCE platform, clarifying development strate...
Regentis Biomaterials Receives Japan Patent Allowance for GelrinC Manufacturing Technology
Regentis Biomaterials announced a Japan patent allowance for its organic solvent-free manufacturing process for GelrinC, a cartilage repair treatment,...
MindBio Therapeutics Advances Voice-Based AI for Real-Time Impairment Detection
MindBio Therapeutics is developing an AI-powered voice analysis platform to detect drug and alcohol impairment in real time, targeting a growing $4.2 ...
New Study Links Gut Microbes to Improved Cancer Immunotherapy Response
A recent study has identified that metabolites produced by certain gut bacteria can enhance patient responses to cancer immunotherapy, offering potent...
SS Innovations Appoints Veteran Medtech CFO as Global Robotic Surgery Expansion Accelerates
SS Innovations International Inc. (NASDAQ: SSII) has appointed Sarah M. Romano as CFO, bringing over two decades of public-company finance and capital...
Creative Biolabs Integrates Microfluidics and Electrochemical Biosensors to Accelerate Next-Generation POCT Diagnostics
Creative Biolabs expands its development platform combining microfluidics and electrochemical biosensors to enable robust, scalable point-of-care test...
BioAdaptives Details Xcellara Platform Strategy Ahead of XcellaraHeart Launch
BioAdaptives outlines its Xcellara cellular wellness platform, backed by a clinical trial showing a 268.8% increase in stem/progenitor cells, ahead of...
NeuroOne Collaborates with Mayo Clinic on Pediatric Brain Cancer Trial Using Drug Delivery Technology
NeuroOne Medical Technologies announced a collaboration with Mayo Clinic to evaluate a novel drug delivery approach for pediatric diffuse midline glio...
Oncotelic Therapeutics Launches AI-Powered Manufacturing Platform to Aid Biotech Firms
Oncotelic Therapeutics introduces an AI and robotics-driven GMP manufacturing platform to help emerging biotech companies overcome infrastructure chal...
Quantum BioPharma Advances Multiple Sclerosis Therapy LUCID-MS into Phase 2 Trials
Quantum BioPharma is progressing its proprietary multiple sclerosis therapy LUCID-MS, which targets myelin repair, into Phase 2 clinical trials after ...
VERAXA Biotech Leverages AI Collaboration to Enhance Cancer Drug Development
VERAXA Biotech's partnership with AI-focused Ardigen aims to accelerate its BiTAC oncology platform through AI-enabled target discovery, potentially i...
Tonix Pharmaceuticals Publishes Mpox Research Supporting TNX-801 Vaccine Development
New preclinical research published in the Journal of Virology shows that the mpox virus clade IIb, circulating in the U.S., is up to 100,000 times les...
Nuvectis Pharma Prices $100 Million Public Offering to Advance Pipeline
Nuvectis Pharma announced a $100 million public offering to fund development of its drug candidates for complement-mediated diseases and oncology.
Kairos Pharma Reports Favorable Interim Phase 1 Safety Data for ENV-105 in EGFR-Mutated Lung Cancer
Kairos Pharma announced positive interim safety results from its Phase 1 trial of ENV-105 combined with osimertinib for patients with advanced EGFR-mu...
NeuroThera Labs Initiates Phase IIb Trial for Tourette Syndrome Treatment at Hannover Medical School
NeuroThera Labs has started a Phase IIb clinical trial for its cannabinoid-based treatment SCI-110 in adults with Tourette Syndrome at Hannover Medica...
Earth Science Tech Inc. Leverages Telehealth and Peptide Therapies to Capture Growing Markets
Earth Science Tech Inc. is strategically positioning itself in the rapidly expanding telehealth and peptide therapy markets through proprietary techno...
Formycon and OneSource Specialty Pharma Forge Strategic Biosimilar Manufacturing Partnership
Formycon AG and OneSource Specialty Pharma announce a strategic manufacturing partnership to leverage OneSource's Indian facility for cost-efficient b...
Quantum BioPharma Advances Multiple Sclerosis Therapy LUCID-MS to Phase 2 Trials
Quantum BioPharma Ltd. is progressing its neuroprotective therapy LUCID-MS, which targets myelin repair in multiple sclerosis, into Phase 2 clinical t...
Quantum BioPharma Advances Multiple Sclerosis Therapy LUCID-MS into Phase 2 Trials
Quantum BioPharma has reported favorable safety data from Phase 1 studies of its multiple sclerosis treatment LUCID-MS and submitted an IND to the FDA...
Silo Pharma Subsidiary QwikAgents Joins AMD AI Developer Program to Accelerate AI Agent Platform
Silo Pharma's subsidiary QwikAgents has been accepted into AMD's AI Developer Program, gaining access to cloud credits and tools to advance its AI age...
VERAXA Biotech Leverages AI to Enhance BiTAC Cancer Therapy Platform
VERAXA Biotech's AI collaboration with Ardigen aims to optimize its BiTAC platform for cancer therapy, highlighting the growing role of AI in drug dis...
DN Group subsidiary Algene achieves first microalgae harvest, starts series production
Algene Holding SE, a subsidiary of DN Group AG, has completed its first harvest of high-purity microalgae with a yield of 4,500 liters, marking the st...
VERAXA Biotech Partners With Ardigen to Leverage AI for Cancer Drug Development
VERAXA Biotech announced a collaboration with Ardigen to use artificial intelligence for advancing its BiTAC pipeline of T-cell engagers, aiming to im...
NanoViricides Receives Ethics Approval for Phase II Ebola Trial in DRC
NanoViricides has received National Ethics Committee approval in the DRC for a Phase II trial of its oral NV-387 gummies against Bundibugyo ebolavirus...
Tonix Pharmaceuticals Expands TONMYA Medicare Coverage to 145 Million Lives
Tonix Pharmaceuticals announces a major managed Medicare agreement for TONMYA, expanding pharmacy coverage to approximately 145 million covered lives,...
VERAXA Biotech Partners with Ardigen to Integrate AI into Cancer Drug Development
VERAXA Biotech AG has announced a collaboration with Ardigen S.A. to use artificial intelligence to enhance its BiTAC pipeline of T-cell engagers and ...
Onco-Innovations Completes Analytical Reference Standard Program for Lead Drug Candidate ONC010
Onco-Innovations Limited has finished its analytical reference standard program for the API supporting ONC010, strengthening CMC framework for clinica...
VERAXA Biotech Appoints Carl von Halem as Interim CFO Amid Leadership Transition
VERAXA Biotech has appointed Carl von Halem as interim CFO while finalizing a permanent candidate to support its next phase of growth.
Novel Feeder-Free TIL Expansion Platform Reduces IL-2 Dependence, Enhances Safety and Efficacy in Preclinical Study
A new study presents a feeder-free TIL expansion protocol that minimizes reliance on high-dose IL-2, potentially making TIL therapy safer and more acc...